Skip to main content

Unable to load price data. Sorry.



CAPS Rating: No stars

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:CPHD.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

KatWoman50 (71.96)
Submitted July 29, 2008

Genetic analysis for diagnostic, industrial and biothreat markets. Picked up from Penny after 30% drop on earnings report. Slowdown in biothreat business leading drop but core staph test is solid and stock should come back now that it's out ot such… More

zzlangerhans (97.88)
Submitted September 14, 2010

I'm taking advantage of an off day to go through my watchlist and see who broke through my rating thresholds. Cepheid is up steeply in September on the back of some positive press about their new TB test. That's all well and good, but it remains… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CPHD.DL.

No one has written a Pitch for CPHD.DL stock yet. Tell us why you think CPHD.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in CPHD.DL.

No players have picked CPHD.DL yet. Tell us why you think CPHD.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CPHD.DL.